These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34365450)

  • 41. Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Cen J; Ma H; Chen Z; Weng L; Deng Z
    Respir Med; 2019 Mar; 148():43-48. PubMed ID: 30827473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ambient benzene and toluene on emergency COPD hospitalizations: A time series study in Hong Kong.
    Ran J; Sun S; Yang A; Yang L; Han L; Mason TG; Chan KP; Li J; Tian L
    Sci Total Environ; 2019 Mar; 657():28-35. PubMed ID: 30530216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease - pilot study.
    Białas AJ; Liberski PP; Zielińska A; Kumor-Kisielewska A; Szewczyk K; Miłkowska-Dymanowska J; Sitarek P; Piotrowski WJ; Górski P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2313-2318. PubMed ID: 30104871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.
    Reumkens C; Endres A; Simons SO; Savelkoul PHM; Sprooten RTM; Franssen FME
    ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37228266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
    Martinez FJ; Lipworth BJ; Rabe KF; Collier DJ; Ferguson GT; Sethi S; Feldman GJ; O'Brien G; Jenkins M; Reisner C
    Respir Res; 2020 May; 21(1):128. PubMed ID: 32450869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-life burden of hospitalisations due to COPD exacerbations in Spain.
    Izquierdo JL; Rodríguez JM; Almonacid C; Benavent M; Arroyo-Espliguero R; Agustí A
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35983537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
    Camac ER; Voelker H; Criner GJ;
    Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
    Crisafulli E; Sartori G; Huerta A; Gabarrús A; Fantin A; Soler N; Torres A
    Chest; 2023 Dec; 164(6):1422-1433. PubMed ID: 37516272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly.
    Taylor SP; Sellers E; Taylor BT
    Am J Med; 2015 Dec; 128(12):1362.e1-6. PubMed ID: 26291905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
    Hernández Cordero AI; Yang CX; Li X; Milne S; Chen V; Hollander Z; Ng R; Criner GJ; Woodruff PG; Lazarus SC; Connett JE; Han MK; Martinez FJ; Reed RM; Man SFP; Leung JM; Sin DD
    Respir Res; 2021 Dec; 22(1):316. PubMed ID: 34937547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation.
    Quintana JM; Esteban C; Garcia-Gutierrez S; Aguirre U; Gonzalez N; Lafuente I; Bare M; Fernandez de Larrea N; Rivas-Ruiz F;
    Respiration; 2014; 88(4):298-306. PubMed ID: 25228470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol.
    Calverley PM; Martinez FJ; Fabbri LM; Goehring UM; Rabe KF
    Int J Chron Obstruct Pulmon Dis; 2012; 7():375-82. PubMed ID: 22791991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Inquiries: Does prophylactic azithromycin reduce the number of COPD exacerbations or hospitalizations?
    Lyon C; Radi R; Staff T; Nashelsky J
    J Fam Pract; 2018 Jun; 67(6):384-385. PubMed ID: 29879240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
    Pavord ID; Chapman KR; Bafadhel M; Sciurba FC; Bradford ES; Schweiker Harris S; Mayer B; Rubin DB; Yancey SW; Paggiaro P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1755-1770. PubMed ID: 34163157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments.
    Quintana JM; Esteban C; Unzurrunzaga A; Garcia-Gutierrez S; Gonzalez N; Barrio I; Arostegui I; Lafuente I; Bare M; Fernandez-de-Larrea N; Vidal S;
    BMC Med; 2014 Apr; 12():66. PubMed ID: 24758312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.